NBTY to Web Cast Presentation at RBC Capital Markets Consumer Conference
26 9월 2005 - 9:30PM
PR Newswire (US)
BOHEMIA, N.Y., Sept. 26 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced that it
will web cast the presentation by Harvey Kamil, President and Chief
Financial Officer of NBTY, at the RBC Capital Markets Consumer
Conference in Orlando, Florida on Thursday, September 29, 2005. The
conference is being held at the Grand Floridian Resort & Spa.
The presentation is scheduled to be web cast live on the Company
Web site, http://www.nbty.com/ on Thursday, September 29, 2005 at
11:00AM Eastern Time. ABOUT NBTY NBTY is a leading vertically
integrated manufacturer, marketer and distributor of a broad line
of high-quality, value-priced nutritional supplements in the United
States and throughout the world. Under a number of NBTY and third
party brands, the Company offers over 19,000 products, including
products marketed the Company's Nature's Bounty(R), Vitamin
World(R), Puritan's Pride(R), Holland & Barrett(R), Rexall(R),
Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American
Health(R), GNC (UK)(R), DeTuinen(R), LeNaturiste(TM), SISU(R) and
Solgar(R) brands. This release contains certain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 with respect to our financial condition, results
of operations and business. These forward-looking statements can be
identified by the use of terminology such as "subject to,"
"believe," "expects," "plan," "project," "estimate," "intend,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy. Although all of these forward looking
statements are believed to be reasonable, they are inherently
uncertain. Factors which may materially affect such forward-looking
statements include: (i) slow or negative growth in the nutritional
supplement industry; (ii) interruption of business or negative
impact on sales and earnings due to acts of war, terrorism,
bio-terrorism, civil unrest or disruption of mail service; (iii)
adverse publicity regarding nutritional supplements; (iv) inability
to retain customers of companies (or mailing lists) recently
acquired; (v) increased competition; (vi) increased costs; (vii)
loss or retirement of key members of management; (viii) increases
in the cost of borrowings and/or unavailability of additional debt
or equity capital; (ix) unavailability of, or inability to
consummate, advantageous acquisitions in the future, including
those that may be subject to bankruptcy approval or the inability
of NBTY to integrate acquisitions into the mainstream of its
business; (x) changes in general worldwide economic and political
conditions in the markets in which NBTY may compete from time to
time; (xi) the inability of NBTY to gain and/or hold market share
of its wholesale and/or retail customers anywhere in the world;
(xii) unavailability of electricity in certain geographical areas;
(xiii) the inability of NBTY to obtain and/or renew insurance
and/or the costs of the same; (xiv) exposure to and expense of
defending and resolving, product liability claims and other
litigation; (xv) the ability of NBTY to successfully implement its
business strategy; (xvi) the inability of NBTY to manage its
retail, wholesale, manufacturing and other operations efficiently;
(xvii) consumer acceptance of NBTY's products; (xviii) the
inability of NBTY to renew leases for its retail locations; (xix)
the inability of NBTY's retail stores to attain or maintain
profitability; (xx) the absence of clinical trials for many of
NBTY's products; (xxi) sales and earnings volatility and/or trends
for the Company and its market segments; (xxii) the efficacy of
NBTY's Internet and on-line sales and marketing strategies; (xxiii)
fluctuations in foreign currencies, including the British Pound,
the Euro and the Canadian dollar; (xxiv) import- export controls on
sales to foreign countries; (xxv) the inability of NBTY to secure
favorable new sites for, and delays in opening, new retail
locations; (xxvi) introduction of and compliance with new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly proposed Good
Manufacturing Practices in the United States, the Food Supplements
Directive and Traditional Herbal Medicinal Products Directive in
Europe and Section 404 requirements of the Sarbanes-Oxley Act of
2002; (xxvii) the mix of NBTY's products and the profit margins
thereon; (xxviii) the availability and pricing of raw materials;
(xxix) risk factors discussed in NBTY's filings with the U.S.
Securities and Exchange Commission; (xxx) adverse effects on NBTY
as a result of increased gasoline prices and potentially reduced
traffic flow to NBTY's retail locations; (xxxi) adverse tax
determinations; (xxxii) the loss of a significant customer of the
Company; and (xxxiii) other factors beyond the Company's control.
Since the first time NBTY will be required to comply with the
certification and other requirements of Section 404 of the
Sarbanes-Oxley Act of 2002 will be for NBTY's fiscal year ending
September 30, 2005, NBTY cannot provide assurances that NBTY, or
NBTY's auditors, will not conclude that there are one or more
material weaknesses in NBTY's internal controls or that measures
NBTY has taken to comply with Section 404 will be sufficient to
meet the requirements thereof. Readers are cautioned not to place
undue reliance on forward-looking statements. NBTY cannot guarantee
future results, trends, events, levels of activity, performance or
achievements. NBTY does not undertake and specifically declines any
obligation to update, republish or revise forward- looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrences of unanticipated events.
Consequently, such forward-looking statements should be regarded
solely as NBTY's current plans, estimates and beliefs. Contact:
Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co.
President & Chief Financial Officer 212-725-4500 631-200-2020
DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, President & Chief
Financial Officer of NBTY, Inc., +1-631-200-2020; or Carl Hymans of
G.S. Schwartz & Co. for NBTY, Inc., +1-212-725-4500, Web site:
http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024